TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 2,852,337 | 2,515,734 | 2,392,534 |
Financial expenses | 3,361 | 21,263 | 1,010 |
Earnings before taxes | 511,580 | 473,177 | 393,300 |
EBITDA | 651,171 | 635,335 | 520,167 |
Total assets | 4,233,220 | 3,882,799 | 3,412,186 |
Current assets | 3,027,669 | 2,720,983 | 2,404,640 |
Current liabilities | 398,994 | 391,765 | 309,344 |
Equity capital | 3,619,099 | 3,299,092 | 2,910,781 |
- share capital | 120 | 120 | 100 |
Employees (average) | 9,734 | 8,336 | 8,141 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 85.5% | 85.0% | 85.3% |
Turnover per employee | 293 | 302 | 294 |
Profit as a percentage of turnover | 17.9% | 18.8% | 16.4% |
Return on assets (ROA) | 12.2% | 12.7% | 11.6% |
Current ratio | 758.8% | 694.5% | 777.3% |
Return on equity (ROE) | 14.1% | 14.3% | 13.5% |
Change turnover | 540,379 | 167,509 | 88,160 |
Change turnover % | 23% | 7% | 4% |
Chg. No. of employees | 1,398 | 195 | 233 |
Chg. No. of employees % | 17% | 2% | 3% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.